Search by Drug Name or NDC

NDC 68180-0521-50 Vigabatrin 500 mg/1 Details

Vigabatrin 500 mg/1

Vigabatrin is a ORAL POWDER, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Lupin Pharmaceuticals, Inc.. The primary component is VIGABATRIN.

MedlinePlus Drug Summary

Vigabatrin tablets are used in combination with other medications to control certain types of seizures in adults and children 10 years of age or older whose seizures were not controlled by several other medications. Vigabatrin powder is used to control infantile spasms (a type of seizure that babies and children can have) in babies 1 month to 2 years of age. Vigabatrin is in a class of medications called anticonvulsants. It works by decreasing abnormal electrical activity in the brain.

Related Packages: 68180-0521-50
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Vigabatrin

Product Information

NDC	68180-0521
Product ID	68180-521_ebee5ec2-b40e-4ac6-a51b-5db2eb496b60
Associated GPIs
GCN Sequence Number	n/a
GCN Sequence Number Description	n/a
HIC3	n/a
HIC3 Description	n/a
GCN	n/a
HICL Sequence Number	n/a
HICL Sequence Number Description	n/a
Brand/Generic	n/a
Proprietary Name	Vigabatrin
Proprietary Name Suffix	n/a
Non-Proprietary Name	Vigabatrin
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	POWDER, FOR SOLUTION
Route	ORAL
Active Ingredient Strength	500
Active Ingredient Units	mg/1
Substance Name	VIGABATRIN
Labeler Name	Lupin Pharmaceuticals, Inc.
Pharmaceutical Class	Anti-epileptic Agent [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA211790
Listing Certified Through	2023-12-31

Package

NDC 68180-0521-50 (68180052150)

Pricing Information	N/A
NDC Package Code	68180-521-50
Billing NDC	68180052150
Package	50 POWDER, FOR SOLUTION in 1 CARTON (68180-521-50)
Marketing Start Date	2022-03-10
NDC Exclude Flag	N